Anti-GPC1 mAb significantly inhibited the growth of the ESCC-8 PDX compared with isotype control mouse IgG2a (67.87% ± 6.28% tumor growth inhibition at day 31) and also tumor weight (Figure 4B). Here, GPC1 is linked to esophageal squamous cell carcinoma.